SCIENTURE HOLDINGS, INC. Accounts Receivable, Allowance for Credit Loss, Recovery
SCIENTURE HOLDINGS, INC. (SCNX) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $98.84 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2024-01-16.
Discontinued › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2024-01-16
- 2022-09-30: Accounts Receivable, Allowance for Credit Loss, Recovery 9 month $98.84K.
- 2021-06-30: Accounts Receivable, Allowance for Credit Loss, Recovery 6 month $10.00K.
- 2020-06-30: Accounts Receivable, Allowance for Credit Loss, Recovery 6 month $0.00.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 9 month |
|---|---|---|
| 2022-09-30 | $98.84K 10-Q · filed 2024-01-16 | |
| 2021-06-30 | $10.00K 10-Q · filed 2021-07-26 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |